Picture of Pulmonx logo

LUNG Pulmonx News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapValue Trap

Pulmonx Corp reports results for the quarter ended in March - Earnings Summary

* Pulmonx Corp  LUNG.OQ  reported a quarterly adjusted loss
of 43
cents​​ per share for the quarter ended in March. The mean
expectation of seven analysts for the quarter was for a loss
of 37 cents per share.
    * Revenue rose 16.7% to $10.79 million from a year ago; 
analysts
expected $9.26 million. 
    * Pulmonx Corp's reported EPS for the quarter was a loss
of 43
cents​.
    * The mean earnings estimate of analysts had fallen by
about 16.3%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Pulmonx Corp shares had risen by 1.1% this quarter and
lost 21.8% so far this year.
    * The company reported a quarterly loss of $15.83 million.
    * Wall Street's median 12-month price target for Pulmonx
Corp is
$32.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 4 at 12:48 a.m.  ​All
figures in US dollars unless otherwise stated

Recent news on Pulmonx

See all news